Hair Loss and GLP-1 Medications: What's Actually Happening

If you've started a GLP-1 medication and noticed more hair in your brush, on your pillow, or circling the shower drain, you're not imagining things, and you're not alone. More than 1,000 spontaneous cases of hair loss in patients on semaglutide, tirzepatide, liraglutide, and dulaglutide have been reported to the FDA's Adverse Event Reporting System. A large real-world cohort study presented at the 2025 European Academy of Dermatology and Venereology Congress, looking at data from nearly 548,000 adults, found that GLP-1 receptor agonist use was independently associated with increased incidence of telogen effluvium and androgenetic alopecia. So this is not anecdotal. There is a signal.

But the more important question is why, because the answer is probably not as simple as "the drug causes hair loss."

Your body doesn't know the difference between intentional weight loss and a famine. When you lose weight rapidly, and GLP-1 medications can produce significant weight loss in a relatively short window, your body interprets that caloric deficit as physiological stress. The hair follicle is one of the most metabolically active structures in the human body, and it is exquisitely sensitive to systemic stress signals. When the body perceives a threat, it triages. It shunts resources toward essential organs and away from things it considers expendable, ie, hair. The result is telogen effluvium, a condition where a disproportionate number of hair follicles prematurely enter the resting phase and then shed, typically showing up 2-3 months after the triggering event. In a normal cycle, about 10% of your follicles are in the resting phase at any given time. In telogen effluvium, that number can spike to 30% or more.

Layered on top of that stress response is the micronutrient problem, and this is significant. GLP-1 medications suppress appetite, which is their primary mechanism for weight management. But reduced food intake means reduced nutrient intake, and several nutrients are non-negotiable for hair follicle cycling. Iron is probably the most significant: ferritin levels below 30 ng/mL have been consistently associated with increased shedding. Zinc plays a critical role in keratin synthesis. Vitamin D receptors are expressed directly in the hair follicle. B12 and biotin matter too. A 2025 U.S. database study of over 461,000 adults on GLP-1 medications found that 12.7% were newly diagnosed with a nutritional deficiency by six months, and 22% by twelve months, with vitamin D deficiency being the most common.

Here is where it gets particularly relevant for women over 50: you may have two things happening at the same time. Telogen effluvium from the rapid weight loss and nutrient depletion, and the unmasking or acceleration of androgenetic alopecia, the hormonally driven, genetically influenced hair thinning that affects approximately 40% of women by menopause. The decline in estrogen that accompanies menopause shifts the androgen-to-estrogen ratio, and follicles that were already genetically susceptible begin to miniaturize. Add a metabolic stressor like rapid weight loss on top of that hormonal shift, and you can get both conditions running concurrently, one temporary, one progressive, each making the other look worse.

So, what should you do about a hair issue?

• Don't wait for the shedding to start. Get your labs checked before or early in treatment: ferritin, zinc, vitamin D, B12.
• Prioritize protein, even when your appetite is suppressed, aiming for at least 1.2-1.6 g/kg of body weight daily.
• Talk to your prescriber about titrating your dose more gradually if weight loss is happening very quickly.
• Ask a dermatologist to evaluate whether what you're seeing is telogen effluvium, androgenetic alopecia, or both, because the treatment strategies are different. And know that telogen effluvium, while distressing, is almost always reversible once the trigger resolves and nutritional status is restored.

Your hair will come back, but you do have to feed it.

‍